Researchers identify how class of drugs blocks Hepatitis C virus replication

(University of North Carolina Health Care) For the first time, researchers at the University of North Carolina at Chapel Hill show how the antiviral class of drugs called NS5A inhibitors interacts with the hepatitis C virus, and these findings show a difference between strains of HCV. These results were published in PLOS Pathogens.